Triple
T1172145
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Tysabri |
E24936
|
entity |
| Predicate | indicationRestriction |
P10734
|
FINISHED |
| Object | generally reserved for patients with inadequate response to other MS therapies |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: generally reserved for patients with inadequate response to other MS therapies | Statement: [Tysabri, indicationRestriction, generally reserved for patients with inadequate response to other MS therapies]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: indicationRestriction Context triple: [Tysabri, indicationRestriction, generally reserved for patients with inadequate response to other MS therapies]
-
A.
hasContraindication
Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
-
B.
indicatedFor
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
-
C.
notableRestriction
chosen
Indicates that there is a significant limitation, constraint, or prohibition that meaningfully affects the entity or its use.
-
D.
hasIndication
Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
-
E.
hasLimitation
Indicates that an entity is subject to a constraint, restriction, or boundary that limits its scope, capability, or applicability.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a494082a7c819095004f423f294a64 |
completed | March 1, 2026, 7:31 p.m. |
| NER | Named-entity recognition | batch_69a4bceb3f188190b8b767380fe5986f |
completed | March 1, 2026, 10:25 p.m. |
| PD | Predicate disambiguation | batch_69a4bb5656948190b0b1d5446ad06005 |
completed | March 1, 2026, 10:19 p.m. |
Created at: March 1, 2026, 7:45 p.m.